Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Press Releases.
Press releases published on July 28, 2025
Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering
GlobeNewswire
·
July 28, 2025
WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects a version issued on July 25, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is not currently affiliated with iSpecimen …
Tilray Brands Reports Fourth Quarter and Fiscal 2025 Financial Results
GlobeNewswire
·
July 28, 2025
Fiscal Year Net Revenue of $821 Million, $834 Million in Constant Currency, Strategic Decisions Impacted Revenue by $35 Million Q4 Consolidated Adjusted EBITDA is the 2nd Highest in the Company’s History International Cannabis Revenue Increased 71% in Q4 …
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GlobeNewswire
·
July 28, 2025
AMF Regulated Information Châtillon, France, July 28, 2025 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical …
Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
GlobeNewswire
·
July 28, 2025
Informations Réglementées Châtillon, France, le 28 juillet (22 h 30 CET) 2025 Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq : DBVT), laboratoire biopharmaceutique …
Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025
GlobeNewswire
·
July 28, 2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced …
Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering
GlobeNewswire
·
July 28, 2025
WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects the version issued on July 24, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is not currently affiliated with …
Assistive Technology Market Projected To Witness Massive Growth, 2025-2032 | Invacare Corporation,Ottobock SE & Co. KGaA
EIN Presswire
·
July 28, 2025
BURLINGAME, CA, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- The Assistive Technology Market is estimated to be valued at USD 25.34 Bn in 2025 and is expected to reach USD 35.66 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 5% …
Abivax Announces Closing of $747.5 Million Public Offering
GlobeNewswire
·
July 28, 2025
Abivax Announces Closing of $747.5 Million Public Offering PARIS, France, July 28, 2025 – 10:15 p.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing …
Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
July 28, 2025
- Expected cash runway extended into Q3 2027, beyond multiple potential inflection points including Dyne’s first planned commercial launch in early 2027 - - Registrational Expansion Cohort of DELIVER Trial of DYNE-251 in DMD fully enrolled to support …
Precision Medicine Market Projected To Witness Massive Growth, 2025-2032 | Pfizer Inc., Novartis AG, Intomics, GENinCode
EIN Presswire
·
July 28, 2025
BURLINGAME, CA, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- The precision medicine market is estimated to be valued at USD 102.93 Bn in 2025 and is expected to reach USD 220.68 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.5% …
U.S. 503B Compounding Pharmacies Market Projected To Witness Massive Growth 2025-2032 | QuVa Pharma, Olympia, ASP Cares
EIN Presswire
·
July 28, 2025
BURLINGAME, CA, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- The latest report (2025-2032) on the U.S. 503B Compounding Pharmacies Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the …
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine
GlobeNewswire
·
July 28, 2025
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Mont-Saint-Guibert, Belgium – July 28, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology …
Les Données de l'Étude Pivot DREAM de Nyxoah publiées dans le Journal of Clinical Sleep Medicine
GlobeNewswire
·
July 28, 2025
Les Données de l'Étude Pivot DREAM de Nyxoah publiées dans le Journal of Clinical Sleep Medicine Mont-Saint-Guibert, Belgique – 28 juillet 2025, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société …
iMDx to Host Virtual KOL Event to Discuss its In-House dd-cfDNA Testing for Kidney Transplant Patients on August 15, 2025
GlobeNewswire
·
July 28, 2025
NASHVILLE, Tenn., July 28, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics, or iMDx, (Nasdaq: IMDX), today announced that it will host a virtual key opinion leader (KOL) event on Friday, August 15, 2025 at 4:00 PM ET featuring Anthony Langone, MD ( …
AVITA Medical to Announce Second Quarter 2025 Financial Results
GlobeNewswire
·
July 28, 2025
VALENCIA, Calif. and MELBOURNE, Australia, July 28, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced that it will report its second …
Roivant to Report Financial Results for the First Quarter Ended June 30, 2025, and Provide Business Update on Monday, August 11, 2025
GlobeNewswire
·
July 28, 2025
BASEL, Switzerland and LONDON and NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, August 11, 2025, to report its financial results for the …
Celcuity Inc. Announces Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock
GlobeNewswire
·
July 28, 2025
MINNEAPOLIS, July 28, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced proposed underwritten public offerings of $150,000, …
Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress
GlobeNewswire
·
July 28, 2025
MET-097i (fully biased once-monthly GLP-1 RA) VESPER-1 and interim VESPER-3 data release expected in September 2025; Phase 3 initiation on track for late 2025 MET-233i (once-monthly amylin analog) delivered class-leading Phase 1 results including 8.4% five …
Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
GlobeNewswire
·
July 28, 2025
CAMBRIDGE, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …
Health Caregiving Market Projected To Witness Massive Growth, 2025-2032 | Honor Technology, Inc, Vesta Healthcare, Mable
EIN Presswire
·
July 28, 2025
BURLINGAME, CA, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- The Health Caregiving Market is estimated to be valued at USD 233.02 Bn in 2025 and is expected to reach USD 521.61 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 12.2% …